Medikaloka Hermina PT Cash Flow-to-Debt Ratio
Medikaloka Hermina PT cash flow-to-debt ratio. Medikaloka Hermina PT (HEAL) has a Cash Flow-to-Debt Ratio of 0.05x as of June 2025, meaning its operating cash flow of Rp225.37 Billion could theoretically repay 0% of its total liabilities (Rp4.91 Trillion) in one year. Check Medikaloka Hermina PT cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Medikaloka Hermina PT (2015–2024)
Cash flow-to-debt ratio of Medikaloka Hermina PT from 2015 to 2024. Historical debt coverage capacity for Medikaloka Hermina PT across 10 annual periods. Check HEAL operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
Medikaloka Hermina PT Cash Flow-to-Debt Ratio by Year (2015–2024)
Medikaloka Hermina PT cash flow-to-debt ratio by year from 2015 to 2024. Year-by-year debt coverage analysis for Medikaloka Hermina PT. For the full cash flow conversion analysis, see Medikaloka Hermina PT operating cash flow efficiency.
| Year | CF-to-Debt Ratio | Operating CF (IDR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.24x | Rp1.14 Trillion | Rp4.71 Trillion | ▼ -34.1% |
| 2023 | 0.37x | Rp1.32 Trillion | Rp3.60 Trillion | ▲ +111.3% |
| 2022 | 0.17x | Rp503.58 Billion | Rp2.91 Trillion | ▼ -70.1% |
| 2021 | 0.58x | Rp1.86 Trillion | Rp3.20 Trillion | ▲ +53.1% |
| 2020 | 0.38x | Rp1.13 Trillion | Rp2.97 Trillion | ▲ +51.1% |
| 2019 | 0.25x | Rp572.58 Billion | Rp2.28 Trillion | ▲ +86.9% |
| 2018 | 0.13x | Rp241.67 Billion | Rp1.80 Trillion | ▼ -31.1% |
| 2017 | 0.19x | Rp465.08 Billion | Rp2.39 Trillion | ▼ -33.4% |
| 2016 | 0.29x | Rp362.85 Billion | Rp1.24 Trillion | ▼ -5.8% |
| 2015 | 0.31x | Rp255.71 Billion | Rp824.54 Billion | — |